Customizing medications can be lifesaving and also dangerous. Understand the advantages and disadvantages of Compounding ...

A 2026 informational consumer research report examining the TMates telehealth weight-loss platform, compounded GLP-1 ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

FORT MYERS, Fla. — Noah Song’s dream of pitching in the major leagues has never been closer. The 2019 Naval Academy product had a chance to skip the minor leagues altogether when the Philadelphia ...

Zealthy is pleased to announce its new physician-supervised telehealth platform designed to provide access to GLP-1 weight-loss treatment. The platform ...

Telehealth company Hims & Hers on Monday announced a “strategic shift” in its business model, partnering with pharmaceutical company Novo Nordisk to sell its blockbuster GLP-1 medication and stop ...

DENVER — Colorado state lawmakers are debating regulations about compounded GLP-1 medications. Senate Bill 26-066 is designed to regulate the ingredients in compounded weight loss medications. “We ...

The Mesa County Women’s Network welcomes back Karen Floyd of Western Colorado Compounding Pharmacy for an informative workshop on hormone health on March 10, 6-8 p.m. at Abstract & Title Company, The ...

A 2026 industry overview of the Direct Meds telehealth platform, including its compounded GLP-1 medication access model, pricing structure, delivery formats, consultation process, pharmacy sourcing, ...

Market OutlookThe US pharmacy market is expected to demonstrate steady expansion between 2024 and 2029, registering a compound annual growth rate of approximately 5–6%. Market growth is primarily ...

NVO partners with HIMS to expand access to Ozempic and Wegovy via telehealth, aiming to shift patients from compounded GLP-1s to FDA-approved drugs.

Our RexMD brand now with approximately 215,000 active patients returned to growth in the second half of 2025 and continues to perform strongly on a profitable basis. We are focused on expanding ...